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The U.S. Environmental Protection Agency’s
(EPA) Office of Pesticide Programs (OPP)
estimated that 891 pesticide active ingredients
were registered in 1997 (Aspelin and Grube
1999) and that 888 million pounds of pesti-
cide active ingredients were used in the United
States in 2001 (Kiely et al. 2004). Few of these
chemicals are applied alone but rather are
applied in formulations using different combi-
nations of several pesticide active ingredients
(MeisterPRO 2004). It is not uncommon for
many classes of pesticides, such as insecticides,
herbicides, and fungicides, to be used on the
same crop (National Agricultural Statistics
Service 2005). In the case of insecticides, an
adjuvant is often added to the formulations to
enhance the intensity of the lethal effect. In the
case of herbicides, due to the increasing inci-
dence of plant tolerance to a speciﬁc pesticide,
some formulations now have as many as three
active ingredients (MeisterPRO 2004). Each
active ingredient has a speciﬁc mode of action
for controlling a pest, and each active ingredi-
ent has its own possible side effects on the
wildlife and humans exposed to it. It is impos-
sible to determine the cumulative risk posed to
wildlife and humans as the result of releasing
vast amounts of pesticide mixtures into the
environment.
The quality and quantity of the data about
the risk posed to humans by individual pesti-
cides vary considerably. In some instances
there are numerous studies about the health
effects of a particular pesticide in humans and
laboratory animals, and for others there are
very few. In general, the longer the active
ingredient has been on the market, the greater
the number of citations in the peer-reviewed
literature. Data are sparse when linking pesti-
cides with neurodevelopmental effects other
than for the insecticides chlorpyrifos (CPF),
parathion, and 1,1,1-trichloro-2,2-bis(p-
chlorophenyl)ethane (DDT).
Unlike obvious structural defects, most
neurodevelopmental effects cannot be seen at
birth or even later in life. Instead, adverse
effects on the nervous system are expressed in
terms of how an individual behaves or func-
tions. Behavior and function vary considerably
from birth through adulthood. Functional
deﬁcits are not “on” and “off” conditions but
instead range from inconsequential through
very mild to very severe to totally debilitating.
Consequently, it is difﬁcult to quantify neuro-
developmental impairment. Some of the end
points used in the laboratory to detect func-
tional impairment of the brain and nervous
system are measured at the gene, cell, bio-
chemical, and/or physiologic levels and often
require high-tech instrumentation to quantify.
At the human level, a battery of tests is con-
tinuing to evolve to measure with increasing
sensitivity psychomotor, psychologic, clinical,
and psychiatric symptoms to better quantify
functional impairment.
In this article I have two principal purposes
in discussing the inherent risks of using pesti-
cides, the limitations of testing techniques, and
the intrinsic incompleteness of all scientiﬁc evi-
dence: a) to encourage the use of the open lit-
erature about the neurodevelopmental effects
of all classes of pesticides when setting the cri-
teria for determining their safety and b)t o
encourage a more rigorous regulatory approach
to protect human and environmental health in
the absence of complete scientiﬁc certainty. I
begin by presenting unequivocal evidence of
pesticide exposure to numerous classes of pes-
ticides during development. This is followed
by a section on human epidemiology where
only weak data are available linking neuro-
developmental impairment with pesticides.
Next, I present a case study of how CPF cryp-
tically interferes with brain development one
stage after another. This is followed with
selected laboratory studies demonstrating that
other insecticides as well as other pesticide
classes target prenatal brain development
similar to CPF and share similar and some-
times diverse impacts on the construction and
function of the brain. As the data reveal, not
only insecticides but other classes of pesticides,
such as herbicides and fungicides, can also
interfere with neurodevelopment. In the
“Discussion” I challenge the protective value of
current pesticide risk assessment strategies in
light of the vast numbers of pesticide products
on the market with untold numbers of targets
and mechanisms of action that can cause
neurodevelopmental damage.
Evidence of Exposure to
Pesticides
Improvements in analytical laboratory equip-
ment and testing procedures have made it
easier to detect pesticides and their metabo-
lites at very low concentrations in almost all
human tissue. From routinely detecting parts
per million (milligrams per kilogram) and
more recently to as low as parts per trillion
(picograms per kilogram), some laboratories
are now able to measure concentrations down
to parts per quintillion (femtograms per kilo-
gram). The development of noninvasive sam-
pling methods, such as testing for pesticides
and their metabolites in urine, has made it pos-
sible to monitor pesticide exposure in infants
and children. It is fairly safe to say that every
child conceived today in the Northern hemi-
sphere is exposed to pesticides from concep-
tion throughout gestation and lactation
regardless of where it is born. The herbicide
2,4-dichlorophenoxyacetic acid (2,4-D) was
found in approximately 50% of semen samples
provided by 97 Ontario, Canada, farmers
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2005.(Arbuckle et al. 1999). The herbicides
atrazine, metolachlor, alachlor, and 2,4-D and
the insecticides diazinon and the CPF analyte
3,5,6-trichloro-2-pyridinol (TCP) were found
in semen of men in central Missouri and in
urban Minneapolis, Minnesota (Swan et al.
2003); the insecticides chlordane, dichloro-
diphenyldichloroethylene (DDE), heptachlor
epoxide, and hexachlorobenzene (HCB) were
found in ovarian follicular ﬂuid from women
undergoing in vitro fertilization in Halifax,
Hamilton, and Vancouver, Canada (Jarrell
et al. 1993); hexachlorocyclohexane and
p,p´-DDE were found in amniotic fluid of
women undergoing routine amniocentesis in
Los Angeles, California (Foster et al. 2000);
and nonpersistent pesticides were found in the
amniotic ﬂuid of women referred for amnio-
centesis in the agricultural San Joaquin Valley,
California (Bradman et al. 2003). Pesticides
were also found in maternal blood, placental,
and umbilical cord blood from women experi-
encing normal births and stillbirths in India
(Saxena et al. 1983), from urban and rural
mothers during Caesarian section in the Atoya
River basin, Nicaragua (Dorea et al. 2001),
and from mothers delivering normal and sub-
normal weight babies (Siddiqui et al. 2003).
In addition, pesticides were found in the
breast milk of mothers who delivered by
Caesarian section in Nicaragua (Dorea et al.
2001), native Alaskan mothers living an
indigenous lifestyle (Simonetti et al. 2001),
and women living in southwest Greece
(Schinas et al. 2000). A median of 8.26 µg/mL
CPF (range, 0.40–458.04 µg/mL) was discov-
ered in the meconium of newborns in Manila,
Philippines (Ostrea et al. 2002). Six organo-
phosphate (OP) pesticide metabolites were
found in the meconium of 20 newborns in
New York City (Whyatt and Barr 2001). The
babies’ ﬁrst bowel movements held concentra-
tions 10–100 times higher than their cord
blood. One metabolite, diethylthiophosphate,
was found in all 20 samples; another, diethyl-
phosphate, was found in 19 of 20 samples.
Both are metabolites of diazinon, CPF, and
several other OP insecticides.
An eastern Washington State research team
surveyed OP metabolites in the urine of
210 farmworkers and their children and in dust
from their homes and vehicles (Coronado et al.
2004). They segregated farm chores into several
classes: harvesting and picking, thinning, load-
ing, transplanting, and pruning. Azinphos-
methyl, an OP, was more often found in dust
in thinners’ homes (92.1% vs. 72.7%) and
vehicles (92.6% vs. 76.5%) than in those of
workers who did no thinning. Thinners’ chil-
dren had higher concentrations of OP metabo-
lites in their urine, and the metabolites were
found more frequently in the children (91.9%
detectable in urine), compared to the adults
(81.3% detectable; p = 0.002).
In Seattle, Washington, investigators
measured ﬁve OP metabolites in 24-hr urine
samples of preschool children (2–5 years of
age) who were raised on either a predomi-
nantly organic (n = 18) or predominantly con-
ventional diet (n = 21) (Curl et al. 2003).
Pesticide use was also recorded for each home.
Median total dimethylphosphate metabolites
(0.06 µmol/L) were signiﬁcantly higher than
median total diethyl alkylphosphates
(0.02 µmol/L; p = 0.0001) in the urine. Those
children on a conventional diet had levels of
dimethylphosphate metabolites six times
higher than those of children on an organic
diet (medians = 0.17 and 0.03 µmol/L, respec-
tively; p = 0.0003). Median concentrations of
both metabolites were almost an order of mag-
nitude higher in the conventionally fed chil-
dren (0.34 µmol/L vs. 0.04 µmol/L). There
were no age differences in the children in the
two groups. Home use of pesticides varied,
with seven conventional-diet families using
OPs versus three organic-diet families using
OPs. Although the study group was small and
there were difﬁculties collecting urine samples,
this research provides the ﬁrst empirical data
comparing urinary levels of pesticides in
youngsters consuming predominantly organic
versus conventional diets.
Human Epidemiology
Determining a link between fetal exposure to
a speciﬁc chemical and long-term expression
of a change in health poses a monumental
challenge when designing epidemiologic stud-
ies. For example, one human epidemiologic
study uncovered weak but statistically signiﬁ-
cant associations between neurodevelopmental
impairment as a result of exposure to two pes-
ticides during gestation. In a large study of live
births (n = 1,532), including 536 children
fathered by pesticide applicators, Garry et al.
(2002) discovered that “adverse neurologic
and neurobehavioral developmental effects
clustered among the children born to applica-
tors of the fumigant phosphine [odds ratio
(OR) = 2.48; 95% confidence interval (CI),
1.2–5.1].” They also discovered an OR for the
herbicide glyphosate (Roundup) of 3.6 (95%
CI, 1.3–9.6). Among the children in the phos-
phine group (n = 290), two were diagnosed
with autism, which is high compared with the
prevalence nationwide, and five were diag-
nosed with attention deﬁcit disorder/attention
deﬁcit hyperactivity disorder (ADD/ADHD).
It took years of close interaction with the fam-
ilies in this study to be able to track their pesti-
cide exposure without having to resort to
recall and to follow the children’s functional
development (Garry VF, personal communi-
cation). The investigators were cautious about
their ﬁndings and asked for conﬁrmation.
Another study suggests that CPF might
have an effect on head circumference related to
the activity of paraoxonase (PON1), an
enzyme that can detoxify CPF before it can
inhibit acetylcholinesterase (Berkowitz et al.
2004). Babies with a small reduction in head
circumference were from mothers whose TCP
concentrations were above the detection limit,
and their PON1 activity was in the lowest ter-
tile (p = 0.014). Mothers and their infants
(n = 404) were recruited from East Harlem
and other sections of New York City.
In a more recent study, Young et al. (2005)
looked at the relationship between maternal
OP urine metabolites and infant neuro-
development. They employed a battery of tests
using the Brazelton Neonatal Behavioral
Assessment Scale for habituation, orientation,
motor performance, range of state, regulation
of state, autonomic stability, and reflex in
381 infants younger than 62 days of age.
Young et al. (2005) found a signiﬁcant associ-
ation between increasing total concentrations
of maternal urine OP metabolites representing
“approximately 80% of OPs used in the
Salinas Valley” and increasing numbers of
abnormal reﬂexes in the infants from days 3 to
62. The median age for testing the infants was
day 3. Mothers’ urine was tested at 14 and
26 weeks during gestation and at day 7 post-
partum. The median urine levels of dialkyl
phosphate (DAP), dimethyl phosphate, and
diethyl phosphate, respectively, were 132, 97,
and 21 mol/L during gestation and 222, 160,
and 27 nmol/L after delivery. DAP represents
the total of diethyl and dimethyl phosphate
metabolites. The dimethyl metabolites could
reflect exposure to malathion, oxydemeton-
methyl, dimethoate, naled, and methidathion,
and the diethyl metabolites could reﬂect expo-
sure to diazinon, CPF, and disulfoton used in
the Salinas Valley. It is important to keep in
mind that the OPs are readily metabolized,
and exposure can vary considerably and most
often is transient and unpredictable. The
authors noted that there were large within-
person variations in urine levels in this study.
A Case Study: The Cryptic
Neurodevelopmental Effects
of CPF
The insecticide CPF is an OP pesticide that
has been on the market since 1965 to control
insects in agriculture, gardens, building con-
struction, and households. In 2002 the use of
CPF was restricted to only agricultural appli-
cations, and all domestic use was to be com-
pletely phased out by 1 January 2005. The
metabolites of CPF have been widely reported
in human tissue. In a study based on data
from the Centers for Disease Control and
Prevention’s (CDC 2001) first National
Report on Human Exposure to Environmental
Chemicals, Hill et al. (1995) found the CPF
analyte TCP in 82% of urine samples
(n = 1,000) from a broad sample of the U.S.
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59 years from all regions of the country. The
CDC’s Second National Report on Human
Exposure to Environmental Chemicals (CDC
2003) states that the levels of TCP were simi-
lar to levels presented in the first National
Report on Human Exposure to Environmental
Chemicals (CDC 2001) but gave no statistics
concerning the extent of exposure across the
population. Like the other OP insecticides,
CPF inhibits the enzyme acetylcholinesterase,
which destroys acetylcholine, the neuro-
transmitter that activates cholinergic neurons.
These are an important group of nerve cells
that control signals in the peripheral nervous
system and in the brain and spinal cord. If
acetylcholine is not inactivated immediately
by the activity of acetylcholinesterase, it over-
stimulates the neurons, and tremors, convul-
sions and death can follow.
As scientists probed deeper into the activ-
ity of CPF, a wealth of information surfaced
from laboratory studies about its effects on the
development and function of the brain and
nervous system in embryos, fetuses, and young
animals. Although many of the studies were
performed on rats and there are differences in
the ontogeny of specific parts of the brain
between rats and humans, the development of
the rat brain through postnatal day (PND) 21
provides a model for the development of the
human brain through to birth.
A series of reports starting in 1991 con-
ﬁrmed that CPF is a cholinesterase inhibitor
and that neonatal rats were more sensitive than
adults when exposed to a single maximum tol-
erated dose (Pope and Chakraborti 1992; Pope
et al. 1991, 1992). These studies also con-
ﬁrmed that the fetus recovers quicker than the
adult from cholinesterase inhibition, suggesting
that the fetus would be protected from CPF if
all the adverse effects were due to cholines-
terase inhibition alone. Lassiter et al. (1998),
however, wrote that although the fetus could
recover faster between repeated doses of CPF,
this was only an “illusion that the fetal com-
partment is less affected than the maternal
compartment.” Realizing that something other
than cholinesterase inhibition was affecting the
fetus, a team from Duke University led by
Theodore Slotkin gradually began to demon-
strate that other mechanisms of action of CPF
alter prenatal development of the brain and
behavior and that the embryo and fetus are
sensitive to cholinesterase inhibition at doses
that would not be toxic to an adult (Qiao et al.
2003; Slotkin 2004). These studies provided
information about how the brain develops and
functions and also provided a chronology of
how CPF interferes at successional stages of
brain development (Qiao et al. 2002). This
team also demonstrated that CPF-oxon, the
active metabolite of CPF, is the compound
that causes cholinesterase inhibition and that
the actual neuroteratogen is CPF (see Slotkin
2004 for a step-by-step description of how
their CPF research progressed).
Slotkin and colleagues demonstrated that
as the brain and nervous system are con-
structed and programmed, there are numerous
points in time and at sites where CPF could
interfere. CPF attacks the neurons that appear
in the earliest stage of brain and central ner-
vous system (CNS) development (Qiao et al.
2004). Neurons process information and are
the signaling or transmitting elements in the
nervous system. Damage to neurons at this
early stage may not be expressed until years
later. For example, a brief subtoxic dose of
CPF [1 or 5 mg/kg body weight (bw)/day]
during neurulation can cause behavioral alter-
ations during adolescence and adulthood
(Icenogle et al. 2004). And, although some
early symptoms of CPF exposure disappear
during certain stages of development, different
neurologic symptoms can appear later in life
(Qiao et al. 2002, 2003, 2004).
Glial cells that appear later than neurons
during early development were shown to be
more vulnerable than neurons to CPF (Qiao
et al. 2002; Roy et al. 2004). There are more
than twice as many glial cells (> 200 billion)
in the body than neurons. Glial cells come in
many varieties; they are supportive cells criti-
cal for normal development and function and
serve as a “scaffold” for migration of cells dur-
ing tissue construction [see Barone et al.
(2000) on brain development]. Glial cells also
provide nutrition to the neurons and provide
a link with the immune system, responding to
damage by acting as scavengers of pathogens
and neuronal debris. CPF preferentially tar-
gets the glial cells among the cells it attacks
(Garcia et al. 2002).
Slotkin and colleagues repeatedly demon-
strated that CPF toxicity is not limited to
cholinesterase inhibition alone but can act by
other mechanisms. For example, in vitro and
in vivo studies at three levels of development
from DNA to the cell and the whole animal
revealed that CPF is far more toxic than previ-
ously thought because of this wider range of
activity (Crumpton et al. 2000). CPF impairs
the binding to DNA of nuclear transcription
factors (AP-1 and Sp1) that modulate cell
replication and differentiation. When undif-
ferentiated and differentiated neurons were
exposed to CPF, the response of some tran-
scription factors varied. Although the activity
of one set of cells might not be affected, the
activity of another set of cells might be signiﬁ-
cantly reduced. An independent study at
Johns Hopkins University (Schuh et al. 2002)
conﬁrmed the ability of CPF to alter the activ-
ity of another nuclear transcription factor in
cortical neurons, the Ca2+/cAMP response ele-
ment binding protein (CREB), which is criti-
cal for cell survival and differentiation during
development and is critical for memory. CPF
increased the activated level of CREB at
0.01 nM, well below the level at which
cholinesterase inhibition is expressed and
below the typical level of human exposure.
Schuh et al. (2002) also demonstrated that
CPF-oxon did not cause the alteration, sup-
porting the conclusion of Crumpton et al.
(2000) that CPF is more than a cholinesterase
inhibitor. Crumpton et al. (2000) also
demonstrated that the CPF effects on the
development of the forebrain in the rat, which
reaches its peak stage of development during
gestation, were not as severe as the effects on
the cerebellum, which reaches its peak 2 weeks
after birth. The cerebellar changes in the later
stages of development, however, could not
have been the result of cholinesterase inhibi-
tion because the cerebellum is not innervated
with cholinergic receptors like the forebrain is
(Crumpton et al. 2000).
Much of the research undertaken by
Slotkin and colleagues demonstrated that
models of adult toxicity do not extrapolate to
fetuses and would not predict the vulnerability
of the embryo to TCP and CPF (Aldridge
et al. 2004, 2005a). The ever-changing state of
the embryo makes it a more sensitive model
for toxicity and a better predictor of long-
term, delayed effects. Slotkin and colleagues
have demonstrated that the embryo and fetus
reveal innumerable mechanisms of action of
toxicity that could not be detected in an adult
animal. For example, in a series of in vitro
studies, a 25% increase in reactive oxygen
species (ROS) was found 10 min after undif-
ferentiated glial C6 cells were exposed to CPF
(Garcia SJ et al. 2001). During some stages of
development, selected regions of the brain are
vulnerable to CPF by interference with the
G-protein in the adenylyl cyclase (AC) cascade
by disrupting nuclear transcription DNA
binding (Meyer et al. 2003; Slotkin 1999).
CPF caused abnormal tissue/cell development
in cultured rat embryos through vacuolation
of the cytoplasm (Roy et al. 1998). CPF,
CPF-oxon, and TCP inhibit DNA synthesis
in PC12 cells (typical neuronal cells) and C6
cells (typical glial cells), having a greater effect
on the glial cells, with the exception of the
TCP (Qiao et al. 2001). Qiao et al. (2001)
also showed that CPF is a stronger DNA syn-
thesis inhibitor than CPF-oxon, although it is
a weaker cholinesterase inhibitor. Conﬁrming
again that certain regions of the developing
brain were more susceptible than others, Qiao
et al. (2001) found that CPF and TCP sup-
press DNA synthesis in the epithelium of the
forebrain and inhibit neural cell replication.
These studies also revealed that serum binding
proteins can be protective of DNA antimitotic
activity, but because fetuses and newborns
have lower concentrations of serum proteins
than adults, they could be more vulnerable.
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at damage in rats from the embryo to the
adult, Slotkin and colleagues demonstrated
again that assays using adult animals cannot
predict the long-term delayed effects in the
offspring. For example, within hours after
9.5-day-old embryos were exposed to CPF,
they showed clear signs of damage that was
restricted to the primordial brain (Roy et al.
1998). Upon histologic examination, Roy
et al. (1998) found apoptosis and altered
mitotic ﬁgures, along with gross disruption of
the architecture of the developing brain, all in
the absence of any gross morphologic defects
in the other parts of the embryo. As these ani-
mals matured, CPF damage was demonstrable
in a wide variety of brain regions. The most
vulnerable target was the hippocampus, with
the damage expressed both as deﬁcits in nerve
activity and as corresponding behavioral
abnormalities (Icenogle et al. 2004). Dosing
an adult animal similarly would not have pro-
voked these effects of fetal origin.
The complexity of the toxicity of CPF
became more apparent as sex-related differ-
ences began to appear in in vivo assays. The
sex-related changes occur when CPF exposure
takes place during gestation days (GD) 17–20
(late gestation) and PND1–4 and again at
PND11–14. The timing of this exposure in
the rat is comparable to human brain develop-
ment during the perinatal and neonatal period
(Aldridge et al. 2004; Meyer et al. 2004a;
Slotkin et al. 2001). Late prenatal exposure to
CPF has also been shown to cause long-term
sex-speciﬁc changes in cognitive performance
(Levin et al. 2002). Adolescent and adult
females were more vulnerable to CPF, based
on their number of errors during working- and
reference-memory tasks. Levin et al. (2002)
also found profound differences between ani-
mals exposed to 1 mg/kg and 5 mg/kg CPF,
reﬂecting a U-shaped dose curve. The lowest
dose was the most potent in this case, although
the highest dose caused the most inhibition of
fetal brain cholinesterase. The non-monotonic
dose–response curve discovered in the assay,
combined with the fact that the results were
not dependent on cholinesterase inhibition,
raises questions about indirect effects of CPF
and its metabolites on the endocrine system via
the brain. However, as Slotkin (personal com-
munication) pointed out, hormesis cannot be
ruled out until further research proves other-
wise. In light of their findings, Levin et al.
(2002) noted the need for childhood and ado-
lescent maturation studies and for the develop-
ment of more sex-selected end points.
At a concentration somewhat higher than
human exposure, 50 µg/mL CPF in vitro
induces the release of norepinephrine from rat
brain synaptosomes (Dam et al. 1999). Studies
using whole animals conﬁrmed that the release
of norepinephrine inhibits synaptogenesis, a
condition that persists to adulthood and is sex
specific, long after exposure ceases and
cholinesterase activity is restored (Levin et al.
2002). Aldridge et al. (2004) showed that CPF
administered during GD9–12 up-regulated
serotonin (5-hydroxytryptamine; 5-HT) recep-
tors (5-HT-1 and 5-HT-2) and interfered with
the 5-HT protein transporter from the neural
tube stage through to adulthood. But during
GD17–20, CPF initiated larger effects in
regions with greater numbers of 5-HT nerve
terminals, which were found more in males.
This response continued through PND1–4. In
contrast, the 5-HT protein transporter was
downregulated in females (Aldridge et al.
2004). Aldridge et al. (2005a,b) performed
studies demonstrating abnormalities of
5-HT–related behaviors in developing rats
exposed to CPF. The research that preceded
this report mapped out the ontogeny of sero-
tonin receptors in the brainstem and forebrain
(Aldridge et al. 2003). The authors pointed out
that serotonin disruption has been linked to
appetitive and affective disorders, and the bio-
logic signiﬁcance of these ﬁndings needs to be
clariﬁed. These disorders have been the focus
of increasing research attention in recent years
as the result of the increasing use of prescrip-
tion and and illicit mind-altering drugs.
Other Pesticide Products 
That Interfere with
Neurodevelopment
There are numerous opportunities during ges-
tation where insecticides and products from
several other chemical classes can alter the pur-
pose of a cell, tissue, organ, or system function
in the brain or CNS, much like the discoveries
presented for CPF.
Herbicides. Over the past 15 years, an
Argentinian research team has produced a
series of reports on 2,4-D that is comparable to
the research on CPF. This team discovered
that exposure during lactation to the herbicide
2,4-DBE (the butyl ester of 2,4-D) can alter
brain production of 5-HT and its metabolite,
5-hydroxyindoleacetic acid (5-HIAA), in
adulthood (Bortolozzi et al. 2001; Evangelista
de Duffard et al. 1990; Garcia G et al. 2001).
Concentrations of both dopamine and sero-
tonin changed transiently if the animals were
exposed only through birth (69 mg/kg bw/day
from GD6 to birth; 15 days) and permanently
if delivered to the offspring through breastfeed-
ing as well from GD6 to weaning (30 days).
Duffard et al. (1996) and Rosso et al. (2000)
found that 2,4-D interfered with myelination
in the brain as the result of lactational expo-
sure. This caused changes in behavior patterns
that included apathy, reduced social inter-
action, repetitive movements, tremors, and
immobility in pups exposed to 2,4-D
(Bortolozzi et al. 1999; Evangelista de Duffard
et al. 1995). They also discovered that the
serotoninergic and dopaminergic effects
occurred during postnatal brain development,
similar to the effects of CPF. Bortolozzi et al.
(1999) and Evangelista de Duffard et al. (1995)
also found 2,4-D in breast milk of 2,4-D–fed
mothers and in the stomach content, brain, and
kidney of 4-day-old pups (Sturtz et al. 2000).
Insecticides. Cassidy et al. (1994) reported
that the lowest dose of chlordane used in
their studies (100, 500, 5,000 ng/g/day both
prenatally and postnatally) caused a dose-
dependent reduction in testosterone levels in
females in adulthood. The lowest dose they
used was 10 times lower than the U.S. EPA’s
lowest observed adverse effect level (LOAEL)
for neurologic effects (1,000 ng/g) and
50 times lower than the U.S. EPA’s LOAEL
for developmental effects (5,000 ng/g) of
chlordane (Cassidy et al. 1994). Females
exhibited improved spatial abilities and audi-
tory startle-evoked responses more similar to
male responses, and slight increases in body
weight. Changes in male mating behavior
included shortening of latency to intromis-
sion and increased intromissions. The authors
speculated that pesticides structurally similar
to chlordane cause masculinization of func-
tion and behavior in both sexes because the
pesticides mimic the sex steroids or change
their plasma levels through other enzyme sys-
tems. The two lower doses in this study
prompted greater change than the highest
dose for auditory startle response, mating
behavior, and body weight.
Methoxychlor (MXC), an insecticide
whose toxicity depends on its conversion to
several metabolites, was considered to be an
estrogen for many years and only recently was
discovered to have antiestrogenic and andro-
genic properties as well. To measure neuro-
developmental impacts, Palanza et al. (2002)
fed pregnant CD-1 mice environmentally rele-
vant doses of MXC (0.02, 0.2, and 2.0 µg/g
mother bw/day) from GD11 to GD17 and
examined them on postpartum days 2–15.
Mothers fed the lowest dose spent less time
nursing than the controls, possibly reﬂecting
the inverted U-shaped dose–response curve
expressed by endocrine disruptors. At late ado-
lescence the pups exhibited a reduction in nov-
elty seeking (both the environment and
objects), with a difference between males and
females (Palanza et al. 1999). Male sexual
aggression was reduced at puberty but returned
to normal in adulthood. The reduction in
aggressive behavior in the periadolescent male
CD-1 mouse as a result of MXC exposure
(20 µg/kg/day) occurred at a dose 100 times
lower than the dose at which the Agency for
Toxic Substances and Disease Registry
(ATSDR 2002) deemed would cause no harm
to humans in 1994. The ATSDR recently
withdrew this minimum risk level in light of
new evidence on MXC.
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nigra project to and release dopamine to the
corpus striatum of the brain. This section of
the brain integrates neuromuscular and behav-
ioral information and is involved in the con-
trol of locomotor activity, exploration, and
novelty-induced behavior. It also influences
social–sexual interactions such as aggression
and maternal behavior. The loss of dopamine
function in the neurons connecting the corpus
striatum with the midbrain of humans is the
cause of Parkinson disease. Male offspring of
mice exposed to 20 µg/kg/day MXC had
fewer dopaminelike receptors in their corpus
striatum and were less active than control
females (vom Saal et al. 2003). Females
exposed to the same concentrations showed a
malelike profile in reactivity to novelty.
Similar changes in males and females were
seen in mice exposed to o,p´-DDT in the same
study. In an unrelated study, Lamberson et al.
(2001) discovered increased locomotor behav-
ior in offspring of Sprague-Dawley rats
administered 0.5 mg/kg/day MXC through-
out gestation.
Prenatal exposure to aldrin also causes
delayed neurologic impairment that extends
through to adulthood. Castro et al. (1992)
administered 1 mg/kg aldrin subcutaneously
to female rats daily from conception to birth
and tested their pups on PND1–2 and again
on PND90. On PND90, the animals showed
loss of locomotor control and behavioral
change(s). Aldrin was not measurable in the
animals at the time they were tested.
Paraoxon is the oxidized metabolite of
parathion and a potent OP cholinesterase
inhibitor. Chronic paraoxon exposure (0.1,
0.15, or 0.2 mg/kg subcutaneously) during a
stage of rapid cholinergic brain development
from PND8 to PND20 in male Wistar rats
led to reduced dendritic spine density in the
hippocampus without obvious toxic choliner-
gic signs in any of the animals (Santos et al.
2004). Some animals in the two highest dose
groups died in the early days of the study. All
doses caused retarded perinatal growth, and
brain cholinesterase activity was reduced 60%
by PND21.
Johansson et al. (1995) showed that a sin-
gle exposure to a pesticide before or shortly
after birth can sensitize the offspring to low
doses of other pesticides later in life, even
though there are no immediate changes in the
structure and function of the nervous system at
the time of exposure. Only as the exposed indi-
vidual matures do irreversible alterations in
structure and function become evident. The
researchers exposed mice to one dose of DDT
(0.5 mg/kg bw orally) on PND10 and then at
5 months of age exposed them to bioallethrin
(0.7 mg/kg bw) (Johansson et al. 1995) or
paraoxon (0.7 or 1.4 mg/kg bw) for 7 days
(Johansson et al. 1996). When tested 2 months
later, at 7 months of age, the offspring exhib-
ited changes in spontaneous behavior and
cholinergic muscarinic receptor density in the
cerebral cortex, which led to impairment in
learning and memory (Eriksson and Talts
2000). Again, the neurodevelopmental damage
was not seen immediately, but instead took
2 months to be expressed. PND10 in the
mouse is equivalent to the end of the second
trimester in the human. It is during this stage,
from the third trimester of pregnancy through
2 years of age in humans, when the neurotrans-
mitter system in the CNS goes through a
growth spurt (Eriksson 1997). Throughout
these studies the animals showed no clinical
signs of toxic symptoms, and the doses used for
adult treatment in these studies had no imme-
diate effect on the adult. The dose of DDT
used in this study is in the range that human
infants might be exposed to during lactation
today (Smith 1999). Even though the func-
tional and structural outcomes in the above
studies are similar, it should be remembered
that they were caused by different mechanisms.
For example, bioallethrin causes harm by pro-
longing sodium channel openings, whereas
paraoxon inhibits acetylcholinesterase activity;
but they both caused similar neuronal changes,
which raises questions about the combined
effects of pesticide mixtures on development.
These studies support the premise that the dif-
ferences in susceptibility of adults to pesticides
may not be genetic, but rather that suscepti-
bility to pesticides can be acquired by low-dose
pesticide exposure earlier in life.
Insecticide and acaricide. Rat pups dis-
played deficits in learning and retention of
memory after exposure to the organochlorine
insecticide and acaricide endosulfan (6 mg/kg
bw) on PND2–25 (Lakshmana and Raju
1994). The concentrations of the neurotrans-
mitters, noradrenalin, dopamine, and sero-
tonin in the olfactory bulb, hippocampus,
visual cortex, brainstem, and cerebellum either
increased or decreased depending on the days
of examination, PND10 and PND25. The
authors ruled out acetylcholinesterase inhibi-
tion as the cause of the alterations in the pro-
duction of the neurotransmitters because they
found no differences in acetylcholine activity
in any of the regions of the brain used in the
study. They suggested that endosulfan directly
led to a “re-altering” of the construction of
those parts of the brain. By PND25, as the
differentiation and organization of the
observed tissues proceeded in the presence of
endosulfan, the rats’ performance became sig-
niﬁcantly compromised.
Fungicides. Gray and Ostby (1998) pro-
vided an excellent overview of how prenatal
exposure to a fungicide can alter sexual behav-
ior and function in adulthood, even though
growth and viability are not compromised.
The neurobehavioral alterations quantiﬁed in
the studies they reviewed include activity level,
aggression, mounting frequency, and com-
pleted intromissions. In a study using the
fungicide vinclozolin, Gray et al. (1994)
reported that 100% of the exposed males failed
to attain intromission, although there was no
reduction in mounting behavior. In subse-
quent studies, newborn male and female rats
were injected on PND2 and PND3 with
200 mg/kg vinclozolin and observed for social
behavior on PND36 and PND37 (Hotchkiss
et al. 2002). Both males and females exhibited
changes in play behavior. Females became
involved in increased rough-and-tumble play, a
behavior imprinted by male hormones in the
brain during early development. Conversely,
the males’ rough-and-tumble play was reduced,
and they behaved more like unexposed
females. Because only one dose was used, this
study does not indicate the lowest dose needed
to initiate these changes. More recently, on
PND34 Colbert et al. (2005) found signifi-
cantly increased nape contact, pounce, pin,
and wrestle play behavior in male offspring of
females exposed to 6 and 12 mg/kg bw/day
vinclozolin from GD14 to PND3. At a mater-
nal dose of 1.5 mg/kg bw/day vinclozolin,
there was a signiﬁcant increase in penile dys-
function in adulthood. Future studies should
include more than one dose, preferably over
several orders of magnitude, to take into
account the susceptibility and sensitivity of the
developing animal.
Discussion
There is a great deal of uncertainty about the
neurodevelopmental effects of pesticides
among the human studies presented here.
Exposure has become too complex because of
the hundreds of pesticide active ingredients on
the market, confounded by background expo-
sure to industrial chemicals that share similar
effects. In addition, functional changes are
expressed over a continuum, making it difﬁcult
to document the damage which often is
expressed as more than one lesion and at differ-
ent intervals or stages of development. The
pesticides discussed here, with the exception of
DDT, are still widely used in the United States
despite these data. Although this information is
available, the U.S. EPA has rarely used the
open literature in its risk assessments, generally
using only data submitted by manufacturers.
Industry continues to use traditional toxico-
logic protocols that test for cancer, reproduc-
tive outcome, mutations, and neurotoxicity, all
crude end points in light of what is known
today about functional end points. In using
manufacturer data, the U.S. EPA misses almost
all delayed developmental, morphologic, and
functional damage of fetal origin and, in the
case of CPF and all OPs, continues to rely pri-
marily on blood cholinesterase inhibition data
in risk assessments (Zheng et al. 2000). The
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literature to determine the toxicity of a chemi-
cal. For example, Brucker-Davis (1998) pub-
lished a comprehensive review of the open
literature in which she found 63 pesticides that
interfere with the thyroid system—a system
known for more than a century to control
brain development, intelligence, and behavior.
Yet, to date, the U.S. EPA has never taken
action on a pesticide because of its interference
with the thyroid system.
It would be difﬁcult to ﬁnd another pesti-
cide in use today that has been as systemati-
cally studied as CPF. The amazing litany of
diverse mechanisms discovered in the series of
CPF studies raises serious questions about the
safety of not only CPF and the other OPs but
all pesticides in use today. Most astounding is
the fact that a large part of CPF’s toxicity is
not the result of cholinesterase inhibition, but
of other newly discovered mechanisms that
alter the development and function of a num-
ber of regions of the brain and CNS. These
ﬁndings send a warning that even though an
OP pesticide like CPF may have a very high
EC50 (concentration that produces 50% of the
maximum possible effective response) for
acute toxicity as a result of cholinesterase inhi-
bition, it may have other toxic strategies that
are far more egregious than cholinesterase
inhibition. This raises a question about the
value of using EC50 values if they do not rep-
resent the most sensitive end point. Qiao et al.
(2003) warn that “developmental neurotoxic-
ity consequent to fetal or childhood CPF
exposure may occur in settings in which
immediate symptoms of intoxification are
absent.” They also point out that in the case of
CPF, damage is not always global (referring to
the entire brain) but may only interfere in spe-
ciﬁc regions of the brain during development,
which could increase the difﬁculty of detecting
the damage. S.J. Garcia et al. (2001) state that
“measurement just of cholinesterase activity is
a questionable approach in assigning an
appropriate index of safety.”
The knowledge gained from a decade of
the CPF/brain studies by Slotkin and col-
leagues and the 2,4-D/brain studies by
Evangelista de Duffard and co-workers not
only demonstrates the insidious nature of CPF
and 2,4-D exposure, but it also demonstrates
the weaknesses in current standard practices
for determining the safety of a pesticide or any
other synthetic chemical. These discoveries
demonstrate that a much larger battery of tests
must be used when determining the safety of
commercial pesticides. Even a U.S. EPA
analysis of developmental neurotoxicity stud-
ies stated that the U.S. EPA’s current develop-
mental neurotoxicologic testing protocol is
“not a sensitive indicator of toxicity to the off-
spring” and urged the U.S. EPA “to further
consider if it will use literature data” (Makris
et al. 1998). In this case, “literature data”
refers to all of the peer-reviewed reports con-
cerning the pesticide impacts on neuro-
development that heretofore have not been
used for risk assessment by the agency. In the
case of CPF and 2,4-D, it appears that those
who reviewed the data failed to understand its
signiﬁcance or had other reasons to ignore it.
The U.S. EPA needs to convene a panel of
independent experts to review these studies for
applicability to determine if and how they can
be used for registration.
Laboratory studies have clearly revealed
neurologic damage after exposure to specific
pesticides and in some studies at concentra-
tions equivalent to ambient exposure. Even so,
the animal testing for regulatory purposes that
takes place today does not attempt to detect
adverse health effects at the concentrations at
which humans are exposed. Instead, the high-
est concentrations of chemicals tested are
those that can be used without killing the ani-
mals or reducing the test mother’s weight and
her reproductive ability. In most animal stud-
ies the pesticides are administered at high oral
or subcutaneous doses orally, not reflecting
that, for most humans and wildlife, exposure
could in many instances be dermal or via
inhalation and, in many cases, over a long
period of time at low doses. The U.S. EPA
currently requires chronic toxicity studies, but
it is locked into using high doses to elicit
effects and has not overcome the difﬁculty of
detecting effects from chronic or ambient
exposure or low doses. In addition, the human
pharmacokinetics of pesticide exposure can
either enhance or reduce the health impacts
depending on individual variations. In some
cases the major or minor metabolites are more
toxic than the parent compound, which is
listed as the active ingredient.
In a recent study, Bowers et al. (2004)
found a different proﬁle of developmental neu-
rotoxicity between polychlorinated biphenyls
(PCBs; such as Aroclor 1254) alone and with a
mixture of organochlorine pesticides. Very low
doses of the chemicals together delayed ear
opening, affected geotaxis, and reduced grip
strength. Ultimately, mortality, growth, thy-
roid function, and neurobehavioral develop-
ment were affected. It is safe to say that there
are very few people in the developed world
today who are not carrying PCBs in their bod-
ies. If animal testing continues to be used for
determining the safety of pesticides, at least
one group of the test animals should be
exposed to PCBs before testing the pesticides
for their ability to cause unpredictable inter-
active effects such as those described above.
It should be pointed out that the same sig-
naling systems (AC cAMP) involved in the sex-
selective changes in brain development have
also been shown to alter heart and liver func-
tion in adulthood (Meyer et al. 2004a, 2004b).
The AC system is ubiquitous throughout the
body. In the future, the most efﬁcient, compre-
hensive assays will take advantage of the fact
that most chemicals have more than one effect
in one system. Cross-disciplinary teams will be
required to design these assays so that every
organ system is carefully screened for damage.
And most important, this will reduce by thou-
sands the numbers of animals needed for test-
ing. However, improved neurodevelopmental
tests with laboratory animals will not fulfill
their greatest potential if they are not backed
up by better batteries of tests to detect func-
tional disabilities in children. Such new,
sophisticated quantitative tests are now avail-
able and are being updated regularly. These
tests go beyond diagnostic testing to “perfor-
mance evaluation” and are designed to detect
the subtle effects of chronic, low-dose exposure
(Davidson et al. 2000).
In conclusion, an entirely new approach to
determine the safety of pesticides is needed. It
is evident that contemporary acute and
chronic toxicity studies are not protective of
future generations. The range of doses used in
future studies must be more realistic, based on
levels found in the environment and human
tissue. In this new approach, functional neuro-
logic and behavioral end points should have
high priority, as well as the results published in
the open literature. In every instance, the
impacts of transgenerational exposure on all
organ systems must be meticulously inven-
toried through two generations on all contem-
porary-use pesticides and new pesticide
coming on the market. To protect human
health, however, a new regulatory approach is
also needed that takes into consideration this
vast new knowledge about the neurodevelop-
mental effects of pesticides, not allowing the
uncertainty that accompanies scientific
research to serve as an impediment to protec-
tive actions.
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